Parecoxib
ApprovedUNKNOWN 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Emergence Delirium
Conditions
Emergence Delirium, Postoperative Pain
Trial Timeline
Sep 1, 2010 → Jun 1, 2012
NCT ID
NCT01221025About Parecoxib
Parecoxib is a approved stage product being developed by Pfizer for Emergence Delirium. The current trial status is unknown. This product is registered under clinical trial identifier NCT01221025. Target conditions include Emergence Delirium, Postoperative Pain.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01221025 | Approved | UNKNOWN |
Competing Products
1 competing product in Emergence Delirium
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Desflurane + Propofol | Baxter | Approved | 82 |